A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine - Concepedia

Concepedia

Publication | Open Access

A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine

DOI Full Paper Access

12

Citations

30

References

2019

Year

Mohammad Masoudi, M. Seki, Razieh Yazdanparast, Nozomu Yachie, Hiroyuki Aburatani

Scientific Reports

References

	Year	Citations

Page 1